Search for: "Pharms v. U.s.*" Results 181 - 200 of 324
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
The CAFC cites Ruschig in Novozymes case on written description.
23 Jul 2013, 8:43 am by Lawrence B. Ebert
Ariad Pharm., Inc. v.Eli Lilly & Co. , 598 F.3d 1336, 1343 – 45 (Fed. [read post]
IPBiz - http://ipbiz.blogspot.com/
Precedential No. 34: In "Expedited Cancellation" Proceeding, TTAB Denies Petition to Cancel MYST Registration for Musical Entertainment Services
10 Dec 2018, 3:45 am
Par Pharm. [read post]
The TTABlog - http://thettablog.blogspot.com/
The Kamstrup case at the CAFC
12 Aug 2022, 6:48 pm by Lawrence B. Ebert
Teva Pharms. [read post]
IPBiz - http://ipbiz.blogspot.com/
D.C. Circuit Affirms District Court Ruling Concerning Losartan 180-Day Exclusivity Forfeiture Issue
6 Jul 2010, 11:03 am by FDABlog HPM
Circuit’s March 2, 2010 decision in Teva Pharms USA, Inc. v. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Patent Games Cannot Save Blockbuster Remicade Patent
23 Jan 2018, 7:29 pm by Dennis Crouch
Teva Pharm. [read post]
Patently-O - http://patentlyo.com/patent
Perfect 10 v. Amazon Opinion Amendment--Ninth Circuit Does 180 on Fair Use Burden for Preliminary Injunction
4 Dec 2007, 5:55 pm
Andrx Pharms., Inc., 473 F.3d 1196, 1201 (Fed. [read post]
Technology & Marketing Law Blog - http://blog.ericgoldman.org/
Synthes v. Spinal Kinteics: No Written Description when Single Species Disclosed and Additional Species Are 'Fairly Unpredictable' in the Art
30 Oct 2013, 8:32 am
See Ariad Pharms., Inc. v. [read post]
Journal of the Patent and Trademark Office Society - http://jptos.org
Takeda v. Zydus: No Margin of Error for a Precisely Claimed Size and Theoretical Arguments Insufficient to Invalidate Claim
15 Jun 2014, 6:18 pm
” Takeda at *14 (quoting Ariad Pharms., Inc. v. [read post]
Journal of the Patent and Trademark Office Society - http://jptos.org
Patent Law Institute Live Blog: Recent Cases
16 Feb 2012, 8:07 am by Stephanie Figueroa
Caraco Pharm. [read post]
Patent Law Practice Center - http://patentlawcenter.pli.edu
Patent Law Institute Live Blog: Recent Cases
16 Feb 2012, 8:07 am by Stephanie Figueroa
Caraco Pharm. [read post]
Patent Law Practice Center - http://patentlawcenter.pli.edu/
Denial of interim patent term extension affirmed
5 Oct 2007, 9:35 am
  The first dealt with obviousness.To read the full decision in Somerset Pharms., Inc. v. [read post]
Filewrapper.com - http://www.filewrapper.com/index.cfm
Overreaching in patent claims dooms Gevo in district court. No infringement because of estoppel and invalidity through lack of enablement.
6 Aug 2013, 8:36 am by Lawrence B. Ebert
Co. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Apotex Seeks to Trigger 180-Day Exclusivity for Generic LEXAPRO Tablets
17 Jan 2011, 9:27 am by FDABlog HPM
USA, Inc. v. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Written Description, Disclosed Embodiments, and BRI
10 May 2017, 10:41 am by Dennis Crouch
Patent No. 6,415,082. [2] Ariad Pharm., Inc. v. [read post]
Patently-O - http://patentlyo.com/patent
CAFC finds no 121 safe harbor for Janssen as to claims of U.S. Patent No. 6,284,471
23 Jan 2018, 9:34 am by Lawrence B. Ebert
Bristol-Myers SquibbCo. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
CAFC does personal jurisdiction in a reprise of "The Good, the Bad. and the Ugly, with Apple as Tuco and Zipit as the one armed man
19 Apr 2022, 8:00 am by Lawrence B. Ebert
Apr. 1, 2020), which in turn quotes Breckenridge Pharm., Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
CAFC discusses APA’s requirements of notice and an opportunity to respond in Emerachem case
15 Jun 2017, 9:02 am by Lawrence B. Ebert
Biomarin Pharm. [read post]
IPBiz - http://ipbiz.blogspot.com/
Child Pornography, "Torrential Downpour" and the Fourth Amendment
7 Oct 2015, 3:28 am
U.S. v. [read post]
CYB3RCRIM3 - http://cyb3rcrim3.blogspot.com/
Ninth Circuit Provides Guidance on SEC Rule 16b-3 Short-Swing Profit Liability Exemption
17 Nov 2023, 3:34 pm by John Stigi and John Mysliwiec
Shire Pharms. [read post]
Corporate Securities Law Blog - http://www.corporatesecuritieslawblog.com/
When is an the inherent, but unexpected result obvious?
17 Jul 2017, 3:18 pm by Dennis Crouch
In the end, the reversal makes sense, but the law created is somewhat of a mess. = = = = = [1] Millennium Pharm., Inc. v. [read post]
Patently-O - http://patentlyo.com/patent